Global Health Ltd's Q3FY25 Quarterly Results
- 05 Feb 2025
Result Summary
- Global Health Ltd reported a 1.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 12.3%.
- Its expenses for the quarter were down by 2.9% QoQ and up 12.9% YoY.
- The net profit increased 9.2% QoQ and increased 15.6% YoY.
- The earnings per share (EPS) of Global Health Ltd stood at 5.3 during Q3FY25.
Financial Statments for Q3FY25
Total Income | 959.46 | 974.77 | 854.53 | -1.6% | 12.3% |
Total Expenses | 770.40 | 793.68 | 682.17 | -2.9% | 12.9% |
Profit Before Tax | 189.07 | 181.10 | 172.36 | 4.4% | 9.7% |
Tax | 46.21 | 50.28 | 48.82 | -8.1% | -5.3% |
Profit After Tax | 142.86 | 130.81 | 123.54 | 9.2% | 15.6% |
Earnings Per Share | 5.30 | 4.90 | 4.60 | 8.2% | 15.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Global Health Ltd is a prominent player in the healthcare industry, primarily engaged in offering a wide range of medical services and products. The company is known for its comprehensive healthcare solutions, which include hospital services, diagnostics, and preventive health care. As of the latest update available, Global Health Ltd has been focusing on expanding its service offerings and enhancing its operational efficiencies. However, specific recent developments about the company are not provided in the data available for this analysis.
Revenue
In Q3FY25, Global Health Ltd reported a total income of ₹959.46 crores. This marks a slight decrease of 1.6% compared to the previous quarter, Q2FY25, where the total income was ₹974.77 crores. On a year-over-year basis, there was a significant increase of 12.3% from Q3FY24, when the total income was ₹854.53 crores. This data indicates changes in revenue generation over different periods, reflecting the company's financial inflows from its operations during the specified quarters.
Profitability
The profitability of Global Health Ltd in Q3FY25 showed positive dynamics, with a profit before tax recorded at ₹189.07 crores, representing a quarterly increase of 4.4% from Q2FY25's ₹181.10 crores and a year-over-year growth of 9.7% from Q3FY24's profit before tax of ₹172.36 crores. The tax for Q3FY25 was ₹46.21 crores, which decreased by 8.1% from the previous quarter and by 5.3% from the same quarter last year. Consequently, the profit after tax stood at ₹142.86 crores, up by 9.2% QoQ and 15.6% YoY, indicating the company's net earnings after tax obligations. The earnings per share for Q3FY25 was ₹5.30, compared to ₹4.90 in Q2FY25 and ₹4.60 in Q3FY24, showing quarterly and yearly growth of 8.2% and 15.2%, respectively.
Operating Metrics
Total expenses for Global Health Ltd were reported at ₹770.40 crores in Q3FY25, reflecting a decrease of 2.9% compared to Q2FY25's expenses of ₹793.68 crores. On a year-over-year basis, there was an increase of 12.9% from ₹682.17 crores in Q3FY24. These figures illustrate the company's expenditure in maintaining and running its operations. The reduction in quarterly expenses alongside the increase in annual expenses highlights the variations in cost management and operational scale. The operating metrics provide insight into the company's ability to manage costs relative to its revenue-generating activities over the analyzed periods.